`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`ACRUX DDS PTY LTD. & ACRUX LIMITED
`Petitioners,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and VALEANT
`PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner and Licensee
`
`
`
`Case: IPR2017-00190
`U.S. Patent No. 7,214,506
`
`
`PETITIONER’S MOTION TO SEAL
`
`
`
`1
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.14 and 42.54 and the Board’s Default Protective
`
`Order filed in these proceedings, Petitioners hereby move to seal the following
`
`categories of exhibits:
`
`(1) Deposition transcripts of Mr. Thomas and Dr. Tatsumi designated by
`
`Patent Owner as containing confidential information under the
`
`Board’s Default Protective Order;
`
`(2) Rebuttal Declaration of Petitioner’s expert, John C. Staines, Jr.; and
`
`(3) An exhibit marked as Patent Owner’s Ex. 2110 served on Petitioners
`
`and designated by Patent Owner as containing confidential
`
`information under the Board’s Default Protective Order. As Patent
`
`Owner has not made this Exhibit of record in this inter partes review,
`
`Petitioners file it herewith as Petitioners’ Ex. 1663.
`
`The record of an inter partes review proceeding, including documents and
`
`things, is made available to the public, except as otherwise ordered. 37 C.F.R. §
`
`42.14. Despite the default rule of public availability, the Board will seal
`
`confidential information for “good cause,” because it is necessary to “strike a
`
`balance between the public’s interest in maintaining a complete and
`
`understandable file history and the parties’ interest in protecting truly sensitive
`
`information.” 37 C.F.R. § 42.54(a); 77 Fed. Reg. 48756, 48760 (Aug. 14, 2012).
`
`
`
`2
`
`
`
`It is Petitioners’ understanding that information in the following documents
`
`has been designated as confidential to Patent Owner, pursuant to the Board’s
`
`Default Protective Order:
`
` Portions of Ex. 1506 (Tatsumi Transcript);
`
` Portions of Ex. 1507 (Thomas Transcript);
`
` Portions of Rebuttal Declaration of Petitioner’s expert, John C.
`
`Staines, Jr.; and
`
` Ex. 1663 (also marked as Patent Owner’s Ex. 2110).
`
`Patent Owner has requested that Petitioners file these documents under seal
`
`and file an appropriate motion to seal under the Board’s Default Protective Order.
`
`Petitioners have no independent basis for the aforementioned documents to be
`
`sealed and thus make no assertion as to whether or not they contain confidential
`
`information.
`
`Petitioners contacted Patent Owner regarding this Motion to Seal and Patent
`
`owner did not oppose.
`
`
`
`
`
`
`
`
`
`
`
` Respectfully submitted,
`
`Date: November 1, 2017
`
`By:
`
`/s/ Aydin H. Harston
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`Lisa N. Phillips, admitted pro hac vice
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`3
`
`
`
`
`
`
`
`
`
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040
`Fax: 202-783-6031
`Counsel for Petitioners
`
`
`
`
`
`
`
`4
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing PETITIONER’S
`
`MOTION TO SEAL was served electronically via email on November 1, 2017, in
`its entirety on the following:
`
`
`John D. Livingstone
`john.livingstone@finnegan.com
`KakenIPR@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`271 17th Street, N.W., Suite 1400
`Atlanta, GA 30363-6209
`
`Naoki Yoshida
`naoki.yoshida@finnegan.com
`Anthony Hartmann
`Anthony.hartmann@finnegan.com
`Barbara R. Rudolph, Ph.D.
`barbara.rudolph@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`901 New York Ave., N.W.
`Washington, DC 20001-4413
`
`Toan P. Vo
`toan.vo@bausch.com
`Valeant Pharmaceuticals North America LLC
`1400 N. Goodman Street
`Rochester, NY 14609
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By:
`
`/s/ Aydin H. Harston _______________
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040 | Fax: 202-783-6031
`
`
`
`
`
`Counsel for Petitioners
`
`5
`
`